Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia

NCT04948008 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Familial Hypercholesterolemia - Homozygous
Lipid Metabolism Disorders
Proprotein Convertase Subtilisin/Kexin 9

Interventions

BIOLOGICAL: IBI306

Sponsor

Shenzhen People's Hospital